SEC Form 5 · accession 0001209191-17-007566
Kura Oncology, Inc. · KURA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heidi Henson
Officer — Chief Financial Officer
Period of report
Dec 31, 2016
Accepted (ET)
Feb 3, 2017 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 11, 2015 | G | 3,000 | $0.00 | D | 247,596 | D | |
| Common Stock | Dec 13, 2016 | G | 2,596 | $0.00 | D | 245,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This is a bona fide gift transaction exempt under Section 16(b). This transaction did not involve the sale of securities.